Maintain neutral weight with disciplined add/trim framework; risk-reward ~1:1 at 25.4x PE in hawkish macro regime
Hold with disciplined add/trim triggers is the highest-probability expression of the two-sided risk without abandoning the structural franchise (300mm cost moat, 35% ROE, 80,000+ SKU captive fab model, 2.18-2.23% dividend carry, 23-year hike streak) or committing to magnitudes that recent reflections empirically penalize.
| Position | Action |
|---|---|
| Confirmed daily close >$274 on >6M volume with 3-day follow-through AND evidence of yield regime softening | Upgrade to Overweight with measured add |
| Flush to $242-248 on heavy volume followed by reversal day with macro stabilization | Deep-value re-entry, upgrade to Overweight |
| Confirmed close <$258 on >5M volume with MACD line accelerating negative | Downgrade to Underweight with 15-20% trim |
| Sustained close <$250 with 50/200 SMA death cross confirmation | Expand trim to 25-30% |
| Any escalation in China tariff rhetoric confirmed by policy action | Immediate Underweight at 25-30% trim as binary downside event triggered |
TXN is a compounding machine with cyclical torque entering an accelerating recovery phase, where its 300mm fab capacity built during the 2024 trough ($4.45B revenue) is now driving multi-year high gross margins of 61.4% and 51.8% YoY EPS growth.
| Indicator | Value | Signal |
|---|---|---|
| 200 SMA | $243.56 | bullish |
| 50 SMA | $271.52 | bearish |
| 10 EMA | $266.29 | bullish |
| MACD | -0.58 | neutral |
| MACD Signal | -2.76 | bearish |
| MACD Histogram | +2.18 | bullish |
| RSI | 54.02 | neutral |
| ATR | $8.56 | neutral |
| Close | $270.65 | neutral |
Support: 260 · 253.34 · 245 | Resistance: 271.52 · 285 · 300
Overall Bias: Cautiously Bullish — short-term momentum is improving (MACD, RSI, 10 EMA), but the stock needs to reclaim the 50 SMA at $271.52 to confirm the bounce. Long-term trend (200 SMA) remains firmly intact, providing a safety net. A confirmed MACD bullish crossover in the next 1-2 sessions would strengthen the buy case. Until the 50 SMA is reclaimed, treat this as a bounce within a corrective phase rather than a new uptrend. FINAL TRANSACTION PROPOSAL: HOLD
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Then: Add/establish position
↩ rebuts: “Bear 'legacy stock, lower growth ceiling' concern—Q2 2026 EPS grew 51.8% YoY directly contradicts growth ceiling thesis; growth is a function of cycle position, not product category”
EV: $300+ in 1-3 months on confirmation of MACD bullish crossover and 50 SMA reclaim · concedes: Forward PE of 25.4x is elevated relative to historical TXN multiples and reflects the recovery being partially priced in; Macro headwinds (10Y at 2007 highs, 97% probability of zero Fed cuts) are real and could delay the technical breakout; Estimate revisions have not yet accelerated to confirm the fundamental inflection is durable; Price sitting 0.3% below 50 SMA creates short-term technical uncertainty until reclaimed
TXN faces a cyclical peak at the worst possible macro moment—with the Fed hiking into 5% yields, multiple compression risk is severe, the 300mm CapEx is a depreciation liability, and the bull case requires seven concurrent tailwinds that are unlikely to materialize.
· concedes: The dividend provides income while waiting for better entry; Q2 2026 results were objectively strong (22.8% revenue growth, 51.8% EPS growth); TXN's analog position remains #1 globally; If the death cross fails to materialize and the macro stabilizes, the bull case could prove correct
→ vs conservative: Macro concern framing (Fed hiking, 10-year yields at 2007 highs, multiple compression inevitable) is "weather report," not analysis — risk is universally recognized and fully priced, stop being a risk and becomes the new floor; TXN held $253 low from September 1 and is putting in higher lows despite worst possible macro backdrop — not behavior of broken stock
→ vs conservative: 200 SMA at $243 is 11% below current price — waiting for it means buying after the setup has worked, after MACD crossover has fired, after SOX has confirmed its turn, after yields have likely rolled over; that's a strategy of paying a premium to chase a trade that has already proven itself
→ vs conservative: Management doesn't raise dividend 7% to $1.52 quarterly (23 consecutive years) when they see cyclical peak forming — board put capital behind view that Q2 inflection is durable
→ vs neutral: Anchoring to 50 SMA at $271.52 as verdict when it's one data point in larger bullish convergence being ignored; MACD histogram four consecutive positive bars (0.45 to 2.18) is not trend deterioration, it's momentum exhaustion on sell side transitioning into fresh bullish crossover
→ vs neutral: Inventory barely budging from $4.80 billion to $4.61B despite 13.2% sequential revenue growth is bullish signal, not bearish — inventory declining while revenue accelerates means demand outrunning supply rebuild; calling for cyclical peak same quarter gross margin printed 61.4% and free cash flow nearly doubled sequentially is fighting the tape
Market Cap
$247.17B
PE Ratio (TTM)
41.19
Forward PE
25.43
PEG Ratio
0.97
Price/Book
13.72
EPS (TTM)
$6.57
Forward EPS
$10.64
Dividend Yield
2.23%
Beta
1.31
52-Week High
$334.03
52-Week Low
$152.73
50-Day Avg
$271.88
200-Day Avg
$245.31
Gross Margin (TTM)
58.3%
Operating Margin
42.6%
Net Margin
31.1%
Return on Equity
35.2%
Return on Assets
13.1%
TTM Revenue
$19.45B
Q2 2026 Revenue
$5.46B
2025 Revenue
$17.68B
2024 Revenue
$15.64B
2023 Revenue
$17.52B
FY 2021 Revenue
$20.03B
2025 Net Income
$5.00B
2025 EPS
$5.45
Q2 2026 EPS
$2.14
TTM FCF
$3.55B
Q2 2026 FCF
$2.19B
2025 CapEx
$4.55B
Total Assets
$35.88B
Total Debt
$14.05B
Net Debt
$10.39B
Debt/Equity
78.0%
Current Ratio
4.86
2025 Dividends
$5.00B
2025 Buybacks
$1.48B
Total 2025 Capital Return
$6.48B
Inventory
$4.61B
Strengths
Concerns
TXN is a high-quality, cyclically-recovering analog semiconductor leader with best-in-class capital efficiency (35.2% ROE), reliable dividend, and clear early-cycle margin expansion. The setup favors patient investors with a 12–24 month horizon, though the stock is not deeply undervalued at current levels — much of the cyclical recovery appears priced in. Recommend monitoring for sustained margin expansion and any moderation in capex intensity before adding aggressively.
Macro: Hawkish Fed pivot dominates: rates raised at Sep 16 FOMC, 10Y Treasury spiked to highest since 2007, 30Y to 2004 highs. Prediction markets price 97% probability of zero Fed rate cuts in 2026 (up +1.6pp w/w; $8.5M Polymarket volume). Jamie Dimon flagged sticky inflation. SOX rallied 4 consecutive sessions counter-trend but macro backdrop remains hostile for long-duration tech/semiconductor multiples.